Janney Montgomery Scott
MRNA icon

Janney Montgomery Scott’s Moderna MRNA Stock Holding History

Janney Montgomery Scott’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
16,278
-4,538
-22% -$235K ﹤0.01% 1840
2026
Q1 		$1.06M Sell
20,816
-1,284
-6% -$59.9K ﹤0.01% 1622
2025
Q4 		$652K Sell
22,100
-18,908
-46% -$514K ﹤0.01% 2026
2025
Q3 		$1.06M Sell
41,008
-5,321
-11% -$148K ﹤0.01% 1654
2025
Q2 		$1.28M Buy
46,329
+32,504
+235% +$856K ﹤0.01% 1437
2025
Q1 		$392K Buy
13,825
+3,744
+37% +$133K ﹤0.01% 2147
2024
Q4 		$419K Sell
10,081
-2,686
-21% -$128K ﹤0.01% 2101
2024
Q3 		$853K Buy
12,767
+756
+6% +$69.4K ﹤0.01% 1614
2024
Q2 		$1.43M Sell
12,011
-2,362
-16% -$299K ﹤0.01% 1264
2024
Q1 		$1.53M Buy
14,373
+4,003
+39% +$403K ﹤0.01% 1286
2023
Q4 		$1.03M Sell
10,370
-4,076
-28% -$343K ﹤0.01% 1434
2023
Q3 		$1.49M Sell
14,446
-4,196
-23% -$468K 0.01% 1138
2023
Q2 		$2.27M Sell
18,642
-20,873
-53% -$2.78M 0.01% 1013
2023
Q1 		$6.07M Buy
39,515
+11,876
+43% +$1.96M 0.02% 574
2022
Q4 		$4.96M Sell
27,639
-7,565
-21% -$1.24M 0.02% 678
2022
Q3 		$4.16M Buy
35,204
+11,021
+46% +$1.67M 0.02% 693
2022
Q2 		$3.44M Buy
24,183
+850
+4% +$121K 0.02% 711
2022
Q1 		$4.02M Sell
23,333
-1,517
-6% -$255K 0.02% 658
2021
Q4 		$6.31M Buy
24,850
+7,018
+39% +$2.05M 0.02% 550
2021
Q3 		$6.86M Sell
17,832
-3,075
-15% -$1.13M 0.03% 500
2021
Q2 		$4.91M Sell
20,907
-13,638
-39% -$2.44M 0.02% 593
2021
Q1 		$4.52M Sell
34,545
-40,783
-54% -$5.91M 0.02% 591
2020
Q4 		$7.87M Sell
75,328
-22,226
-23% -$2.25M 0.04% 396
2020
Q3 		$6.9M Buy
97,554
+81,983
+527% +$5.72M 0.04% 385
2020
Q2 		$1M Buy
15,571
+7,575
+95% +$415K 0.01% 1038
2020
Q1 		$239K Buy
+7,996
New +$184K ﹤0.01% 1605

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Janney Montgomery Scott's MRNA Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Moderna (MRNA) stake by 22% in Q2 2026, selling an estimated $235K and leaving 16,278 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Janney Montgomery Scott first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $7.87M in Q4 2020. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Janney Montgomery Scott held 16,278 shares of Moderna worth $1.14M as of Q2 2026.
  • Janney Montgomery Scott sold 4,538 Moderna shares in Q2 2026, an estimated $235K.
  • Moderna made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1840 holding.
  • Janney Montgomery Scott first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Janney Montgomery Scott's Moderna position peaked at $7.87M in Q4 2020.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.